California Public Employees Retirement System’s Adaptimmune Therapeutics ADAP Stock Holding History

California Public Employees Retirement System’s Portfolio ADAP Stock Details ADAP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-250,800	Closed	-$1.33M	–	1551
2021 Q1	$1.33M	Sell	250,800 -23,093	-8%	-$132K	﹤0.01%	2292
2020 Q4	$1.48M	Sell	273,893 -5,300	-2%	-$28.8K	﹤0.01%	2203
2020 Q3	$2.23M	Buy	279,193 +43,486	+18%	+$381K	﹤0.01%	1773
2020 Q2	$2.36M	Buy	235,707 +205,207	+673%	+$1.29M	﹤0.01%	1697
2020 Q1	$83K	Hold	30,500	–	–	﹤0.01%	3152
2019 Q4	$37K	Hold	30,500	–	–	﹤0.01%	3374
2019 Q3	$46K	Hold	30,500	–	–	﹤0.01%	3189
2019 Q2	$123K	Sell	30,500 -5,068	-14%	-$20.7K	﹤0.01%	3047
2019 Q1	$153K	Hold	35,568	–	–	﹤0.01%	2981
2018 Q4	$205K	Sell	35,568 -1,100	-3%	-$8.12K	﹤0.01%	2913
2018 Q3	$497K	Sell	36,668 -1,128	-3%	-$11.8K	﹤0.01%	2669
2018 Q2	$449K	Buy	+37,796	New	+$471K	﹤0.01%	2676
2018 Q1	–	Sell	-42,995	Closed	-$287K	–	3287
2017 Q4	$287K	Buy	+42,995	New	+$332K	﹤0.01%	2877

Other funds holding ADAP

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

California Public Employees Retirement System's ADAP Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Adaptimmune Therapeutics (ADAP) in Q2 2021, closing a stake of 250,800 shares — an estimated $1.33M sold.

California Public Employees Retirement System first reported a position in ADAP in Q4 2017 and held it in 13 quarters. The position peaked at $2.36M in Q2 2020. 82 funds tracked by Wall St. Rank hold ADAP as of Q2 2021.

California Public Employees Retirement System reported no remaining Adaptimmune Therapeutics position as of Q2 2021 after selling out during the quarter.
California Public Employees Retirement System sold 250,800 Adaptimmune Therapeutics shares in Q2 2021, an estimated $1.33M.
California Public Employees Retirement System first reported a position in Adaptimmune Therapeutics in Q4 2017 and held it in 13 quarters.
California Public Employees Retirement System's Adaptimmune Therapeutics position peaked at $2.36M in Q2 2020.
82 funds tracked by Wall St. Rank held Adaptimmune Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.